Vicarious Surgical (RBOT) Accumulated Expenses (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Accumulated Expenses came in at $1.1 million in Q4 2025, down 80.01% year-over-year from $5.3 million in Q4 2024, and up 16.69% quarter-over-quarter from $905000.0 in Q3 2025.
Analysis
Vicarious Surgical (RBOT) Accumulated Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Accumulated Expenses for 6 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Accumulated Expenses fell 80.01% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 80.01% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 80.01% from the prior year.
- Accumulated Expenses was $1.1 million for Q4 2025 at Vicarious Surgical, up from $905000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $5.8 million in Q4 2022 and troughed at $905000.0 in Q3 2025.
- A 5-year average of $3.8 million and a median of $4.2 million in 2021 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses soared 1558.67% in 2021 and tumbled 81.95% in 2025, its largest moves.
- Over 5 years, Accumulated Expenses stood at $4.1 million in 2021, then jumped by 41.73% to $5.8 million in 2022, then retreated by 14.34% to $5.0 million in 2023, then grew by 6.19% to $5.3 million in 2024, then plunged by 80.01% to $1.1 million in 2025.
- The last three Accumulated Expenses figures came in at $1.1 million (Q4 2025), $905000.0 (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 476,777.11 | -14.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 5.57 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 5.01 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 4.98 Mn |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 4.27 Mn |
| Mar 31, 2022 | 3.05 Mn |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 2.09 Mn |
| Mar 31, 2021 | 1.46 Mn |